A Deep Dive into Key Projections and Future Opportunities. The DNA synthesis market continues to witness significant growth, driven by advancements in biotechnology and increased demand for synthetic ...

The Business Research Company’s Phosphoramidite Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- The ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this ...

Whether you’re working in a startup, academic lab, or biopharma R&D team, this eBook offers a window into what’s working now and what’s possible next.

As fermentation processes become more complex, microbial strains must be adapted to meet stricter performance requirements.

Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] At this time, ...

Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Ansa is accepting orders for synthetic DNA constructs ranging from 7.5 kb up to 50 kb for various applications.

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.